DE69534632D1 - Clorimazole metabolite in den behandlung vom sichelzellanämie - Google Patents

Clorimazole metabolite in den behandlung vom sichelzellanämie

Info

Publication number
DE69534632D1
DE69534632D1 DE69534632T DE69534632T DE69534632D1 DE 69534632 D1 DE69534632 D1 DE 69534632D1 DE 69534632 T DE69534632 T DE 69534632T DE 69534632 T DE69534632 T DE 69534632T DE 69534632 D1 DE69534632 D1 DE 69534632D1
Authority
DE
Germany
Prior art keywords
lemenia
clorimazole
sickle
metabolite
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534632T
Other languages
English (en)
Other versions
DE69534632T2 (de
Inventor
Carlo Brugnara
Nader Rafai
Orah Platt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of DE69534632D1 publication Critical patent/DE69534632D1/de
Application granted granted Critical
Publication of DE69534632T2 publication Critical patent/DE69534632T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69534632T 1994-09-16 1995-09-15 Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit Expired - Fee Related DE69534632T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30787494A 1994-09-16 1994-09-16
PCT/US1995/011822 WO1996008242A2 (en) 1994-09-16 1995-09-15 Clotrimazole metabolites in the treatment of sickle cell disease

Publications (2)

Publication Number Publication Date
DE69534632D1 true DE69534632D1 (de) 2005-12-29
DE69534632T2 DE69534632T2 (de) 2006-06-14

Family

ID=23191532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534632T Expired - Fee Related DE69534632T2 (de) 1994-09-16 1995-09-15 Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit

Country Status (3)

Country Link
EP (1) EP0781128B1 (de)
DE (1) DE69534632T2 (de)
WO (1) WO1996008242A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028103A (en) * 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
US7531573B2 (en) * 1994-09-16 2009-05-12 Children's Medical Center Corporation Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
WO1997034589A1 (en) * 1996-03-20 1997-09-25 President And Fellows Of Harvard College Triaryl methane compounds for sickle cell disease
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
AU2962297A (en) * 1996-05-24 1998-01-05 Neurosearch A/S Phenyl derivatives useful as blockers of chloride channels
EP0906273B1 (de) 1996-05-24 2002-10-16 Neurosearch A/S Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
EP1052990A2 (de) 1997-11-14 2000-11-22 Neurosearch A/S Chemische verbindungen mit ionenkanalblockierender aktivität zur behandlung von dysfunktionen des immunsystems
US6800658B2 (en) 1997-11-20 2004-10-05 Children's Medical Center Corporation Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation
US6291449B1 (en) 1998-09-23 2001-09-18 Children's Medical Center Corporation Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours
JP2001523720A (ja) * 1997-11-20 2001-11-27 チルドレンズ メディカル センター コーポレーション 鎌状赤血球病、異常な細胞増殖によって特徴づけられる炎症性疾患、下痢症および伝染性下痢症の治療または予防用の置換１１−フェニル−ジベンザゼピン化合物の使用。
JP2001523717A (ja) * 1997-11-20 2001-11-27 チルドレンズ メディカル センター コーポレーション 異常細胞増殖、下痢および白痢によって特徴付けられる鎌状細胞病、炎症性の疾病を治療または予防するための置換ジフェニルインダノン、インダンおよびインドール化合物の使用
US6992079B2 (en) 1997-11-20 2006-01-31 President Fellows of Harvard College Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
ES2293699T3 (es) 1997-11-20 2008-03-16 President And Fellows Of Harvard College Compuesto 11-fenil-dibenzazepino substituidos utiles para el tratamiento o prevencion de enfermedades caracterizadas por proliferacion celular anormal.
CN103102284A (zh) * 2011-11-09 2013-05-15 南京大学 4-三氟甲基-2，6-二硝基苯水杨醛肟类衍生物的制备及其在抗癌治疗药物中的应用
US20240024335A1 (en) 2020-12-11 2024-01-25 Sanquin IP B.V. Treatment and prevention of anaemia of inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110615A (en) * 1980-02-06 1981-09-01 Yutaka Idota Treating and preventing agent against disease of respiratory organ of chicken
US5273992A (en) * 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ

Also Published As

Publication number Publication date
EP0781128B1 (de) 2005-11-23
EP0781128A2 (de) 1997-07-02
WO1996008242A3 (en) 1996-05-09
WO1996008242A2 (en) 1996-03-21
DE69534632T2 (de) 2006-06-14

Similar Documents

Publication Publication Date Title
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69500089D1 (de) Behandlung von Geflügel
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DK0792144T3 (da) Rengøringsvæv behandlet med vand-i-lipid emulsion
DE69524138D1 (de) Hautbehandlungsmittel
DE69008342D1 (de) Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
DE69829866D1 (de) Sklerotische prothese für die behandlung von altersweitsichtigkeit und anderen augenkrankheiten
DE69509650D1 (de) Behandlung atrialer fibrillationen
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE69825447D1 (de) Gerät zur dermatologischen behandlung
DE69534632D1 (de) Clorimazole metabolite in den behandlung vom sichelzellanämie
DE69512733D1 (de) Reinigungsvorrichtung für Erntemaschine
DE69630947D1 (de) Mittel zur schmerzbehandlung
FI970214A (fi) Droloksifeenin käyttö sydänverisuonitautien hoitamiseksi
DE69530486D1 (de) Behandlung von uteriner fibrosis
DE69402321D1 (de) Krankentrage
DE69506019D1 (de) Vorrichtung zur Behandlung von Schmerz
DE69603635D1 (de) Katheterstruktur für medizinische Behandlung
BR9606298A (pt) Peixe transgênico no tratamento de diabetes
ITPN920087A1 (it) Macchina per il trattamento e la conservazione delle stoviglie.
FI965094A0 (fi) 2,4,6-trijodi-5-substituoituja aminoisoftalaattiestereitä, jotka ovat hyödyllisiä varjoaineina lääketieteellisessä diagnostisessa kuvauksessa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee